drugset / Trial / NCT03580005
A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A 6-week double-blind study to evaluate the safety and efficacy of Quillichew extended release chewable tablets in 4-5 year old children with attention deficit hyperactivity disorder.
Timeline
- Start
- 2018-10-31
- Primary completion
- 2021-10-12
- Completion
- 2021-10-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylphenidate | Small molecule | — | — |